Drugs / Miotox®
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06840158 | Oct 2021 → May 2022 | cerebral palsy | Innopharm LLC | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Miotox | “Investigational drug Trade Name: Miotox®.” NCT06840158 ↗ |